Furthermore, TGF-β provoked CRC metastasis by elevating stromal Act-A in vivo and in vitro, whilst neutralisation of Act-A inhibited the TGF-β pro-metastatic effects [18]. The gene discussed is ACTA1; the disease is colorectal carcinoma.